全股骨抗生素间隔物:复杂假体周围关节感染的有效挽救方案
该回顾性病例系列评估了全股骨抗生素浸渍PMMA骨水泥间隔物分期治疗同侧髋膝关节假体周围感染(PJI)的效果。结论认为该技术是可行的保肢选择但操作要求高。
要点
- 全股骨抗生素间隔物可用于同侧髋膝PJI的分期治疗,无截肢发生。
- 再植入患者中75%保持无感染,7例(58%)仍需抑制性抗生素。
核心结论
- 全股骨抗生素间隔物是复杂同侧髋膝PJI的可行但技术要求高的保肢选择。
- 再植入患者中75%保持无感染,无截肢发生。
研究设计与样本
- 间隔物置入时平均年龄65岁,9例为多微生物PJI,随访为再植入后平均3年。
主要发现
- 12例(92%)平均26周后接受全股骨假体再植入。
- 1例在间隔物置入后41天死于内科并发症。
- 末次随访时3例PJI复发接受清创冲洗,1例因不稳定需翻修髋臼组件。
关键数值与推荐
- 所有间隔物含万古霉素3.0 g/40 g PMMA和庆大霉素3.6 g/40 g PMMA,8例另含两性霉素150 mg/40 g PMMA。
临床怎么用
- 对于同侧髋膝PJI可考虑全股骨抗生素间隔物分期治疗,但需注意技术难度。
- 成功要素可能包括彻底清创、抗菌药物多样性、延长间隔物保留时间和限制反复软组织损伤。
局限性
- 为回顾性设计,随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A simultaneous periprosthetic joint infection (PJI) of an ipsilateral hip and knee arthroplasty is a challenging complication of lower extremity reconstructive surgery. We evaluated the use of total femur antibiotic-impregnated polymethylmethacrylate (PMMA) bone cement spacers in the staged treatment of such limb-threatening PJIs. METHODS: Thirteen patients were treated with a total femur antibiotic spacer. The mean age at the time of spacer placement was 65 years. Nine patients had polymicrobial PJIs. All spacers incorporated vancomycin (3.0 g/40 g PMMA) and gentamicin (3.6 g/40 g PMMA), while 8 also included amphotericin (150 mg/40 g PMMA). Eleven spacers were biarticular. Twelve spacers were implanted through one longitudinal incision, while 8 of 12 reimplantations occurred through 2 smaller, separate hip and knee incisions. Mean follow-up after reimplantation was 3 years. RESULTS: Twelve (92%) patients underwent reimplantation of a total femur prosthesis at a mean of 26 weeks. One patient died of medical complications 41 days after spacer placement. At latest follow-up, 3 patients had experienced PJI recurrence managed with irrigation and debridement. One required acetabular component revision for instability. All 12 reimplanted patients retained the total femur prosthesis with no amputations. Eleven (91%) were ambulatory, and 7 (58%) remained on suppressive antibiotics. CONCLUSION: Total femur antibiotic spacers are a viable, but technically demanding, limb-salvage option for complex PJIs involving the ipsilateral hip and knee. In the largest series to date, there were no amputations and 75% of reimplanted patients remained infection-free. Radical debridement, antimicrobial diversity, prolonged spacer retention, and limiting recurrent soft tissue violation are potential tenets of success. LEVEL OF EVIDENCE: IV.
引用
- Heidenreich MJ, Tetreault MW, Lewallen DG, et al. Total Femur Antibiotic Spacers: Effective Salvage for Complex Periprosthetic Joint Infections. J Arthroplasty. 2021. PMID: 33745797. doi:10.1016/j.arth.2021.02.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。